This is a Validated Antibody Database (VAD) review about rat Rpa2, based on 19 published articles (read how Labome selects the articles), using Rpa2 antibody in all methods. It is aimed to help Labome visitors find the most suited Rpa2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Santa Cruz Biotechnology
mouse monoclonal (9H8)
  • western blot; human; 1:1000; loading ...; fig 5d
Santa Cruz Biotechnology Rpa2 antibody (Santa Cruz, sc56770) was used in western blot on human samples at 1:1000 (fig 5d). Oncogene (2016) ncbi
mouse monoclonal (9H8)
  • western blot; human; fig 8
Santa Cruz Biotechnology Rpa2 antibody (Santa Cruz, sc-56770) was used in western blot on human samples (fig 8). Nucleic Acids Res (2016) ncbi
mouse monoclonal (9H8)
  • western blot; mouse; 1:100; fig 6
Santa Cruz Biotechnology Rpa2 antibody (Santa Cruz, sc-56770) was used in western blot on mouse samples at 1:100 (fig 6). Cell Cycle (2015) ncbi
Abcam
domestic rabbit monoclonal (EPR2846(2))
  • immunocytochemistry; human; fig 3
Abcam Rpa2 antibody (Abcam, ab109394) was used in immunocytochemistry on human samples (fig 3). J Cell Biol (2016) ncbi
domestic rabbit monoclonal (EPR2877Y)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 3
Abcam Rpa2 antibody (Abcam, ab76420) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 3). J Cell Biol (2016) ncbi
domestic rabbit monoclonal (EPR2846(2))
  • western blot; human; 1:1000
Abcam Rpa2 antibody (Abcam, ab109394) was used in western blot on human samples at 1:1000. Nucleic Acids Res (2016) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; human; fig s10
In order to investigate how the von Hippel-Lindau tumor suppressor gene regulates metabolism in renal cell carcinoma, Invitrogen Rpa2 antibody (Thermo Fisher Scientific, PA5-22256) was used in western blot on human samples (fig s10). J Clin Invest (2017) ncbi
Cell Signaling Technology
rat monoclonal (4E4)
  • western blot; mouse; 1:500; loading ...; fig 3c
Cell Signaling Technology Rpa2 antibody (Cell Signaling, 2208T) was used in western blot on mouse samples at 1:500 (fig 3c). Nat Commun (2019) ncbi
rat monoclonal (4E4)
  • immunocytochemistry; mouse; 1:250; loading ...; fig 1b
Cell Signaling Technology Rpa2 antibody (Cell Signaling, 2208) was used in immunocytochemistry on mouse samples at 1:250 (fig 1b). Sci Adv (2019) ncbi
rat monoclonal (4E4)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1i
Cell Signaling Technology Rpa2 antibody (Cell Signaling, 2208T) was used in immunohistochemistry on mouse samples at 1:100 (fig 1i). Sci Adv (2019) ncbi
rat monoclonal (4E4)
  • other; human; loading ...; fig 4c
Cell Signaling Technology Rpa2 antibody (Cell Signaling, 2208) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
rat monoclonal (4E4)
  • western blot; mouse; loading ...; fig 5b
In order to engineer and characterize a second-generation, high-affinity AXL decoy receptor, Cell Signaling Technology Rpa2 antibody (CST, 2208) was used in western blot on mouse samples (fig 5b). J Clin Invest (2017) ncbi
rat monoclonal (4E4)
  • immunohistochemistry; mouse; 1:100; fig 1
  • western blot; mouse
Cell Signaling Technology Rpa2 antibody (Cell Signalling, 2208S) was used in immunohistochemistry on mouse samples at 1:100 (fig 1) and in western blot on mouse samples . Nat Commun (2016) ncbi
rat monoclonal (4E4)
  • western blot; human; fig 5
In order to study NPM-ALK-amplified cell lines resistant to ALK tyrosine kinase inhibitors, Cell Signaling Technology Rpa2 antibody (Cell Signaling Technology, 2208) was used in western blot on human samples (fig 5). Oncogene (2016) ncbi
rat monoclonal (4E4)
  • western blot; human; 1:1000; fig 8
In order to assess links between telomere-dysfunction and centrosome defects in early breast carcinogenesis, Cell Signaling Technology Rpa2 antibody (Cell Signaling, 2208) was used in western blot on human samples at 1:1000 (fig 8). Oncotarget (2015) ncbi
rat monoclonal (4E4)
  • immunocytochemistry; mouse
Cell Signaling Technology Rpa2 antibody (Cell Signaling, 4E4) was used in immunocytochemistry on mouse samples . J Cell Sci (2015) ncbi
rat monoclonal (4E4)
  • western blot; human; 1:1000; fig s5
Cell Signaling Technology Rpa2 antibody (Cell Signaling, 2208) was used in western blot on human samples at 1:1000 (fig s5). Nat Commun (2015) ncbi
rat monoclonal (4E4)
  • western blot; mouse; 1:1000; fig 3
Cell Signaling Technology Rpa2 antibody (cell Signaling Tech, 2208) was used in western blot on mouse samples at 1:1000 (fig 3). Cancer Cell (2015) ncbi
rat monoclonal (4E4)
  • western blot; human; fig 4
Cell Signaling Technology Rpa2 antibody (Cell Signaling, 2208) was used in western blot on human samples (fig 4). Mol Cancer Res (2014) ncbi
rat monoclonal (4E4)
  • immunocytochemistry; human; 1:1000
Cell Signaling Technology Rpa2 antibody (Cell Signaling Technologies, E4A) was used in immunocytochemistry on human samples at 1:1000. Nature (2014) ncbi
Articles Reviewed
  1. Zhang Q, Ji S, Busayavalasa K, Shao J, Yu C. Meiosis I progression in spermatogenesis requires a type of testis-specific 20S core proteasome. Nat Commun. 2019;10:3387 pubmed publisher
  2. Aranda S, Alcaine Colet A, Blanco E, Borras E, Caillot C, Sabidó E, et al. Chromatin capture links the metabolic enzyme AHCY to stem cell proliferation. Sci Adv. 2019;5:eaav2448 pubmed publisher
  3. Zhang Q, Ji S, Busayavalasa K, Yu C. SPO16 binds SHOC1 to promote homologous recombination and crossing-over in meiotic prophase I. Sci Adv. 2019;5:eaau9780 pubmed publisher
  4. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  5. Okazaki A, Gameiro P, Christodoulou D, Laviollette L, Schneider M, Chaves F, et al. Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers. J Clin Invest. 2017;127:1631-1645 pubmed publisher
  6. Kariolis M, Miao Y, Diep A, Nash S, Olcina M, Jiang D, et al. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest. 2017;127:183-198 pubmed publisher
  7. Ahuja A, Jodkowska K, Teloni F, Bizard A, Zellweger R, Herrador R, et al. A short G1 phase imposes constitutive replication stress and fork remodelling in mouse embryonic stem cells. Nat Commun. 2016;7:10660 pubmed publisher
  8. Hoffmann S, Smedegaard S, Nakamura K, Mortuza G, Räschle M, Ibañez de Opakua A, et al. TRAIP is a PCNA-binding ubiquitin ligase that protects genome stability after replication stress. J Cell Biol. 2016;212:63-75 pubmed publisher
  9. Ceccon M, Merlo M, Mologni L, Poggio T, Varesio L, Menotti M, et al. Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency. Oncogene. 2016;35:3854-3865 pubmed publisher
  10. Kanu N, Zhang T, Burrell R, Chakraborty A, Cronshaw J, DaCosta C, et al. RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress. Oncogene. 2016;35:4009-19 pubmed publisher
  11. Yu Z, Huang Y, Shieh S. Requirement for human Mps1/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation. Nucleic Acids Res. 2016;44:1133-50 pubmed publisher
  12. Ortega Atienza S, Wong V, Deloughery Z, Luczak M, Zhitkovich A. ATM and KAT5 safeguard replicating chromatin against formaldehyde damage. Nucleic Acids Res. 2016;44:198-209 pubmed publisher
  13. Domínguez D, Feijoo P, Bernal A, Ercilla A, Agell N, Genescà A, et al. Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress. Oncotarget. 2015;6:28238-56 pubmed publisher
  14. Bravo M, Nicolini F, Starowicz K, Barroso S, Calés C, Aguilera A, et al. Polycomb RING1A- and RING1B-dependent histone H2A monoubiquitylation at pericentromeric regions promotes S-phase progression. J Cell Sci. 2015;128:3660-71 pubmed publisher
  15. Tomas Roca L, Tsaalbi Shtylik A, Jansen J, Singh M, Epstein J, Altunoglu U, et al. De novo mutations in PLXND1 and REV3L cause Möbius syndrome. Nat Commun. 2015;6:7199 pubmed publisher
  16. Selvaraj D, Gangadharan V, Michalski C, Kurejova M, Stösser S, Srivastava K, et al. A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain. Cancer Cell. 2015;27:780-96 pubmed publisher
  17. Parameswaran B, Chiang H, Lu Y, Coates J, Deng C, Baer R, et al. Damage-induced BRCA1 phosphorylation by Chk2 contributes to the timing of end resection. Cell Cycle. 2015;14:437-48 pubmed publisher
  18. Moskwa P, Zinn P, Choi Y, Shukla S, Fendler W, Chen C, et al. A functional screen identifies miRs that induce radioresistance in glioblastomas. Mol Cancer Res. 2014;12:1767-78 pubmed publisher
  19. Gad H, Koolmeister T, Jemth A, Eshtad S, Jacques S, Ström C, et al. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature. 2014;508:215-21 pubmed publisher